Market research
BZ7A.F Bumrungrad Hospital Public Company Limited
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 4B
- P/E ratio
- 22.61
- Analyst target
- Not available
- Dividend yield
- 4.1%
- Beta
- 0.18
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- TH0168A10Z19
- Market cap
- 4B
- P/E ratio
- 22.61
- Analyst target
- Not available
- Dividend yield
- 4.1%
- Beta
- 0.18
About
About Bumrungrad Hospital Public Company Limited
Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the BZ7A.F discussion.
5 years, 5 months ago
Bumrungrad Hospital Public Company Limited is currently in a long term uptrend where the price is trading 5.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.4.
Bumrungrad Hospital Public Company Limited's total revenue sank by 38.6% to $3B since the same quarter in the previous year.
Its net income has dropped by 80.5% to $173M since the same quarter in the previous year.
Finally, its free cash flow fell by 74.2% to $180M since the same quarter in the previous year.
Based on the above factors, Bumrungrad Hospital Public Company Limited gets an overall score of 2/5.